0,978  0,002  Antineoplastic (ovarian cancer)
0,955  0,004  Antineoplastic (colorectal cancer)
0,954  0,004  Antineoplastic (colon cancer)
0,954  0,004  Antineoplastic (lung cancer)
0,940  0,004  Antineoplastic (breast cancer)
0,919  0,002  Antimitotic
0,891  0,003  Cytostatic
0,884  0,007  Apoptosis agonist
0,877  0,002  P-glycoprotein inhibitor
0,853  0,004  Antineoplastic (carcinoma)
0,840  0,005  Angiogenesis inhibitor
0,828  0,005  Prostate cancer treatment
0,795  0,006  Respiratory analeptic
0,795  0,013  Transcription factor NF kappa B inhibitor
0,792  0,010  CYP3A4 substrate
0,790  0,009  TNF expression inhibitor
0,765  0,005  Analeptic
0,752  0,005  Antineoplastic (cervical cancer)
0,746  0,005  NOS3 expression inhibitor
0,746  0,010  CYP2C9 substrate
0,738  0,004  Antineoplastic (squamous cell carcinoma)
0,711  0,005  Antineoplastic enhancer
0,712  0,006  Cytotoxic
0,706  0,006  Proliferative diseases treatment
0,674  0,004  Antineoplastic (lymphoma)
0,665  0,007  Antineoplastic (non-small cell lung cancer)
0,636  0,008  Antineoplastic (pancreatic cancer)
0,616  0,005  Antineoplastic (renal cancer)
0,578  0,027  Antineoplastic (solid tumors)
0,537  0,008  Antineoplastic (endocrine cancer)
0,542  0,019  Antineoplastic (melanoma)
0,525  0,008  ICAM1 expression inhibitor
0,510  0,007  Tubulin antagonist
0,506  0,022  Sensitization
0,480  0,011  Antineoplastic (liver cancer)
0,480  0,038  Immunosuppressant
0,435  0,021  Nitric oxide antagonist
0,435  0,030  Antineoplastic (glioma)
0,398  0,000  Microtubule stabilization
0,398  0,009  Lipocortins synthesis antagonist
0,391  0,003  Actinic keratosis treatment
0,412  0,037  Antineoplastic (brain cancer)
0,397  0,022  Antineoplastic (osteosarcoma)
0,397  0,029  Radiosensitizer
0,396  0,029  Antineoplastic (glioblastoma multiforme)
0,367  0,001  Microtubule formation inhibitor
0,376  0,023  Antineoplastic (lymphocytic leukemia)
0,367  0,017  Contraceptive
0,372  0,026  Antineoplastic (small cell lung cancer)
0,388  0,053  Immunostimulant
0,336  0,025  Eye irritation, high
0,361  0,052  AR expression inhibitor
0,377  0,071  Antileukemic
0,332  0,029  Antineoplastic (sarcoma)
0,350  0,051  CYP3A4 inhibitor
0,326  0,040  Angiogenesis stimulant
0,339  0,064  Antifungal
0,367  0,093  Antibacterial
0,305  0,031  Growth hormone agonist
0,311  0,043  Carcinogenic
0,267  0,008  Cyclooxygenase 3 inhibitor
0,326  0,068  CYP2D6 substrate
0,282  0,039  Abortion inducer
0,253  0,010  Alcohol dehydrogenase substrate
0,312  0,069  Sodium/bile acid cotransporter inhibitor
0,288  0,051  Antineoplastic (bladder cancer)
0,294  0,070  Antineoplastic (multiple myeloma)
0,228  0,007  Transcription factor NF kappa B stimulant
0,241  0,022  Antineoplastic (bone cancer)
0,260  0,051  Mutagenic
0,244  0,037  Antipruritic, non-allergic
0,280  0,078  CYP1A2 substrate
0,218  0,022  Antirickettsial
0,210  0,028  Antifungal enhancer
0,190  0,013  TRPA1 agonist
0,202  0,031  Arachidonic acid antagonist
0,219  0,055  Hepatoprotectant
0,218  0,054  UGT2B7 substrate
0,256  0,094  Cardioprotectant
0,183  0,024  Adenylate cyclase stimulant
0,238  0,080  Teratogen
0,170  0,013  Ca2+-transporting ATPase inhibitor
0,171  0,022  Antineoplastic alkaloid
0,209  0,063  Chemopreventive
0,159  0,014  Anabolic
0,253  0,110  Caspase 3 stimulant
0,207  0,066  UDP-glucuronosyltransferase substrate
0,180  0,050  Interferon gamma antagonist
0,158  0,029  Antineoplastic antibiotic
0,150  0,034  Antineoplastic (uterine cancer)
0,204  0,090  Embryotoxic
0,123  0,014  Na+ K+ transporting ATPase inhibitor
0,161  0,056  Antiacne
0,165  0,067  Restenosis treatment
0,168  0,077  Toxic, respiratory center
0,140  0,050  Cholesterol synthesis inhibitor
0,203  0,119  DNA synthesis inhibitor
0,135  0,055  Alkylator
0,153  0,074  UGT2B9 substrate
0,081  0,003  Tubulin agonist
0,106  0,031  Contraceptive male
0,137  0,069  Anesthetic
0,165  0,102  UGT1A1 substrate
0,175  0,122  NOS2 expression inhibitor
0,093  0,041  3C-Like protease (SARS coronavirus) inhibitor
0,071  0,020  Lipocortins synthesis agonist
0,170  0,125  Antiviral (HIV)
0,123  0,080  Antihemorrhagic
0,060  0,018  Adenylate cyclase 1 inhibitor
0,080  0,038  Glycine receptor agonist
0,136  0,096  UGT1A4 substrate
0,052  0,013  RNA-directed RNA polymerase stimulant
0,069  0,033  Antimycoplasmal
0,081  0,046  Antibiotic
0,051  0,020  Parathyroid hormone antagonist
0,061  0,030  Protein 50S ribosomal subunit inhibitor
0,060  0,033  Postmenopausal disorders treatment
0,065  0,040  Nitric oxide donor
0,166  0,146  Antioxidant
0,109  0,090  Contraceptive female
0,106  0,088  Growth stimulant
0,031  0,016  Purinergic P2X agonist
0,090  0,077  UGT2B11 substrate
0,112  0,101  Protein kinase stimulant
0,055  0,044  Acetyl-CoA transferase 2 inhibitor
0,019  0,009  Telomerase stimulant
0,129  0,120  Prostate disorders treatment
0,117  0,110  Farnesoid X receptor antagonist
0,101  0,096  Aldehyde dehydrogenase inhibitor
0,093  0,091  Adenylate cyclase inhibitor
0,211  0,211  Antipruritic, allergic
0,042  0,041  Estrogen agonist

